Delivery Order SPE2DB20D1004-SPE2DB23FF2E8
Award Date 2/10/23
Potential Completion Date 2/13/23
Potential Value $1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,375.44 firm fixed-price delivery order is for the supply of insulin lispro 100 unit/mL pens. The contract has an ultimate completion date of January 24, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,410.24 delivery order contract is for the supply of Insulin Lispro 100 Unit/mL Pen 3mL, a critical medication for diabetes management. The contract has an ultimate completion date of October 24, 2022 and is a firm fixed-price delivery order. This award is associated with AmerisourceBergen's larger $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,553.84 Firm Fixed Price Delivery Order is for the supply of Insulin Lispro 100 Unit/mL Pen 3mL, a critical diabetes management medication. The contract has an ultimate completion date of August 22, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Insulin Lispro 100 Unit/mL Pen 3mL. The $1,094.10 fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by the parent company, Cencora, Inc., doing business as AmerisourceBergen. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,275.48, is for the delivery of Insulin Lispro 100 Unit/mL Vials (10 mL) to support military healthcare programs. The contract has a firm fixed price and a completion date of July 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $4,091.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of insulin glargine-yfgn U100 pens, a critical diabetes management medication, with a completion date of December 19, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- The federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the delivery of 4,565,833,584 units of Insulin Lispro 100 Unit/mL Pen 3mL. The contract has a ceiling value of $1,531.74 and is a firm-fixed-price delivery order, with a completion date of September 18, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this award is part of the company's broader federal...
- This federal contract award, with ID SPE2DB20D3101|SPE2DB22FJ1H1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,343.28 firm-fixed-price delivery order is for the supply of Insulin Lispro 100 Unit/mL Pen 3mL, a critical diabetes medication. The award is not designated as a set-aside contract. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc.,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,647.52 delivery order is for the supply of insulin lispro medication in 3 mL pen format, with a completion date of December 8, 2021. The contract has a firm fixed price pricing type and does not utilize any set-aside requirements, indicating full and open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award, valued at $3,013.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Insulin Aspart 100 Unit/mL medication, a critical pharmaceutical product used in the treatment of diabetes. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...